Related references
Note: Only part of the references are listed.Analysis of the N-Glycoforms and Immunoactivity of Chinese Yam (Dioscorea opposita Thunb.) Glycoprotein 30CYGP
Cheng Li et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
Xiaodong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Camrelizumab: First Global Approval
Anthony Markham et al.
DRUGS (2019)
Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides
Shiyan Zhu et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma
Yuqin Song et al.
CLINICAL CANCER RESEARCH (2019)
Immuno-oncology drug development goes global
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats
Dan Lu et al.
PLOS BIOLOGY (2019)
Anti-PD1 SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement
William J. J. Finlay et al.
MABS (2019)
Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation
Mingzhu Wang et al.
COMMUNICATIONS BIOLOGY (2019)
The FG Loop of PD-1 Serves as a Hotspot for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy
Danqing Chen et al.
ISCIENCE (2019)
Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
Colleen M. Britain et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Wenfeng Fang et al.
LANCET ONCOLOGY (2018)
Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses
Min Zhao et al.
MBIO (2018)
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
Zhenkun Na et al.
CELL RESEARCH (2017)
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC
William J. Liu et al.
JOURNAL OF IMMUNOLOGY (2017)
Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities
Shujing Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Mizuki Nishino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
An unexpected N-terminal loop in PD-1 dominates binding by nivolumab
Shuguang Tan et al.
NATURE COMMUNICATIONS (2017)
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
Matthew J. Schultz et al.
CANCER RESEARCH (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism
Hao Song et al.
PLOS PATHOGENS (2016)
Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
Shuguang Tan et al.
PROTEIN & CELL (2016)
Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
Shuguang Tan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel et al.
CELL (2015)
Glycosylation-directed quality control of protein folding
Chengchao Xu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
Krzysztof M. Zak et al.
STRUCTURE (2015)
The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer
Jennifer Munkley et al.
ONCOTARGET (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer
Xiangchun Wang et al.
GLYCOBIOLOGY (2014)
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Prakash Radhakrishnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus
Wei Zhang et al.
PROTEIN & CELL (2010)
Enhanced Immune Recognition of Cryptic Glycan Markers in Human Tumors
Thomas E. Newsom-Davis et al.
CANCER RESEARCH (2009)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Pushing the boundaries of molecular replacement with maximum likelihood
RJ Read
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2001)
Share Paper
